摘要
Photodynamic therapy (PDT) with an oxygen-dependent character is a noninvasive therapeutic method for cancer treatment. However, its clinical therapeutic effect is greatly restricted by tumor hypoxia. What's more, both PDT-mediated oxygen consumption and microvascular damage aggravate tumor hypoxia, thus, further impeding therapeutic outcomes. Compared to type II PDT with high oxygen dependence and high oxygen consumption, type I PDT with less oxygen consumption exhibits great potential to overcome the vicious hypoxic plight in solid tumors. Type I photosensitizers (PSs) are significantly important for determining the therapeutic efficacy of PDT, which performs an electron transfer photochemical reaction with the surrounding oxygen/substrates to generate highly cytotoxic free radicals such as superoxide radicals (O-2(-)) as type I ROS. In particular, the primary precursor (O-2(-)) would progressively undergo a superoxide dismutase (SOD)-mediated disproportionation reaction and a Haber-Weiss/Fenton reaction, yielding higher cytotoxic species (OH) with better anticancer effects. As a result, developing high-performance type I PSs to treat hypoxic tumors has become more and more important and urgent. Herein, the latest progress of organic type I PSs (such as AIE-active cationic/neutral PSs, cationic/neutral PSs, polymer-based PSs and supramolecular self-assembled PSs) for monotherapy or synergistic therapeutic modalities is summarized. The molecular design principles and strategies (donor-acceptor system, anion-pi(+) incorporation, polymerization and cationization) are highlighted. Furthermore, the future challenges and prospects of type I PSs in hypoxia-overcoming PDT are proposed.
学科与关键词
- Recent advances in aggregation-induced emission-active type I photosensitizers with near-infrared fluorescence: From materials design to therapeutic platform fabricationXie, Yili; Li, Zhijia; Zhao, Chunhui*; Lv, Ruizhi; Li, Yan; Zhang, Zhihong; Teng, Muzhou*; Wan, Qing*Luminescence : the journal of biological and chemical luminescence , 2024, 39(1).
- Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stressZhuang, Zeyan; Dai, Jun; Yu, Maoxing; Li, Jianqing; Shen, Pjngchuan; Hu, Rong; Lou, Xiaoding; Zhao, Zujin*; Tang, Ben ZhongChemical Science, 2020, 11(13): 3405-3417.被引 164
- Amplifying Free Radical Generation of AIE Photosensitizer with Small Singlet-Triplet Splitting for Hypoxia-Overcoming Photodynamic TherapyXiao, Ya-Fang; Chen, Wen-Cheng; Chen, Jia-Xiong; Lu, Guihong*; Tian, Shuang; Cui, Xiao; Zhang, Zhen; Chen, Huan; Wan, Yingpeng; Li, Shengliang*; Lee, Chun-Sing*ACS applied materials & interfaces, 2022, 14(4): 5112-5121.被引 37
